Article
Cutting Through the Artifacts: Dissecting gRNA Impurities with FUSS-seq
2025-09-17
Abstract excerpt
CRISPR-based therapeutics rely on guide RNAs (gRNAs) and the Cas9 endonuclease for precise gene editing. Ensuring gRNA purity and base-level sequence integrity is essential for clinical translation. While industry-standard practice relies on liquid chromatography-high-resolution mass spectrometry to assess oligonucleotide identity and purity, more recent FDA guidance recommends complementary base-by-base sequence...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b467c0ac-bc63-5d57-9a6c-d49af2e00618
- DOI
- 10.1101/2025.09.13.676056
